URGN icon

UroGen Pharma

81 hedge funds and large institutions have $261M invested in UroGen Pharma in 2020 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 25 increasing their positions, 26 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
81
Holders Change
+1
Holders Change %
+1.25%
% of All Funds
1.44%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
10
Increased
25
Reduced
26
Closed
9
Calls
$2.05M
Puts
$4.97M
Net Calls
-$2.91M
Net Calls Change
-$1.67M
Name Holding Trade Value Shares
Change
Shares
Change %
LC
76
Lindbrook Capital
California
$6K -$219 -13 -4%
Simplex Trading
77
Simplex Trading
Illinois
$5K +$5K +286 New
S
78
SignatureFD
Georgia
$3K -$255 -13 -8%
Daiwa Securities Group
79
Daiwa Securities Group
Japan
$1K -$1.46K -70 -59%
QCG
80
Quadrant Capital Group
Ohio
$1K +$754 +46 +307%
AIG
81
American International Group
New York
$203 -$6 -324 -3%
Artisan Partners
82
Artisan Partners
Wisconsin
-$8.89M -460,970 Closed
MIH
83
Meitav Investment House
Israel
-$934K -48,407 Closed
Norges Bank
84
Norges Bank
Norway
-$868K -45,000 Closed
Jane Street
85
Jane Street
New York
-$419K -21,738 Closed
IC
86
IEQ Capital
California
-$236K -12,250 Closed
AIM
87
Aigen Investment Management
New York
-$207K -10,712 Closed
VCM
88
Vivaldi Capital Management
Illinois
-$233K -10,000 Closed
CG
89
Cutler Group
California
-$67K -3,500 Closed
SPIA
90
Steward Partners Investment Advisory
New York
-$6K -300 Closed